Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
R2 Technology Inc. and Mammography Reporting System Inc. (MRS) have signed a three-year distribution agreement for the MRS Mammography Reporting System.
A series of charges produced a net loss for medical imaging services provider Alliance Imaging Inc. and the resignation of its chairman, Richard N. Zehner.
The federal government on Tuesday indicted former HealthSouth Corp. Chief Executive Richard Scrushy on 85 criminal charges related to an alleged $2.5 billion accounting fraud scheme.
DeJarnette Research Systems has released dyseCT which is intended to decrease the problem of information overload produced by today's high speed, multi-slice CT scanners.
Misys Healthcare Systems announced the opening of its United Kingdom headquarters in Sussex and the appointment of Duane Lawrence as general manager and head of UK International Sales.
GE Medical Systems Information Technologies (GEMSIT) has signed a 10-year agreement with the University of Texas M. D. Anderson Cancer Center in Houston to license and install the GE Centricity Pharmacy system.
Eastman Kodak Co. will provide the Department of Veterans Affairs (VA) several million dollars worth of computed radiography (CR) and digital radiography (DR) systems.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
